Beijing Xinyi Biotechnology

Haidian, China Founded: 2015 • Age: 11 yrs
Micro-droplet digital PCR and diagnostic reagents are manufactured.

About Beijing Xinyi Biotechnology

Beijing Xinyi Biotechnology is a Healthcare company based in Haidian (China) founded in 2015 by Wenjun Yang. Micro-droplet digital PCR and diagnostic reagents are manufactured. Beijing Xinyi Biotechnology has raised $23.19 million across 3 funding rounds from investors including Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics.

Company details

Beijing Xinyi Biotechnology was founded in 2015 and is based in Haidian, China. Operations focus on the biotechnology sector, where micro-droplet digital PCR systems and in vitro diagnostic reagents are produced. Key products encompass drop makers for sample preparation, chip readers, universal PCR amplification reagents, genetic testing kits for research purposes, micro-droplet detection oil, and nucleic acid extraction reagents using magnetic beads. The domain targetingone.com is associated with the company.

  • Headquarters Haidian, China
  • Founders Wenjun Yang
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website targetingone.com
Key Metrics

Funding Insights of Beijing Xinyi Biotechnology

Beijing Xinyi Biotechnology has successfully raised a total of $23.19M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $23.19M
  • Total Rounds 3
  • Investors Count 5

All 3 funding rounds of Beijing Xinyi Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2024Series B–Jiuzhi Capital
–
Jan 2021$23.19MSeries B–Lilly Asia Ventures, China Growth Capital
–
Sep 2018Seed––
Valuation history

5 investors in total: 5 institutional.

Investors in Beijing Xinyi Biotechnology

Beijing Xinyi Biotechnology has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Jiuzhi Capital, Lilly Asia Ventures and China Growth Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Global private equity investments are managed with long-term focus.
hillhouseinvestment.comNew York, United States
lillyasiaventures.com
chinagrowthcapital.com
wonderlandcapital.cn
Premium access

Investor details for Beijing Xinyi Biotechnology

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Beijing Xinyi Biotechnology

1 people are tracked at Beijing Xinyi Biotechnology (1 in leadership).

NameRoleGroup
Wenjun Yang
Co-FounderLeadership
Premium access

Complete people profiles for Beijing Xinyi Biotechnology

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Beijing Xinyi Biotechnology

3 dated milestones of Beijing Xinyi Biotechnology across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Beijing Xinyi Biotechnology is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series B,.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Beijing Xinyi Biotechnology

Premium access

Complete news archive for Beijing Xinyi Biotechnology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Beijing Xinyi Biotechnology

Beijing Xinyi Biotechnology was founded in 2015 and raised its 1st funding round 3 years after it was founded.

Beijing Xinyi Biotechnology is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.

Beijing Xinyi Biotechnology is a funded company, having raised a total of $23.19M across 3 funding rounds to date.

Beijing Xinyi Biotechnology was founded in 2015 and is based in Haidian, China. Operations focus on the biotechnology sector, where micro-droplet digital PCR systems and in vitro diagnostic reagents are produced. Key products encompass drop makers for sample preparation, chip readers, universal PCR amplification reagents, genetic testing kits for research purposes, micro-droplet detection oil, and nucleic acid extraction reagents using magnetic beads. The domain targetingone.com is associated with the company.

Beijing Xinyi Biotechnology has 5 investors. Key investors include Jiuzhi Capital, Lilly Asia Ventures, China Growth Capital, Hillhouse, and Huade Capital Management Group.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available